Summary
The authors report the results of a controlled clinical trial in patients with primitive and metastatic CNS tumours treated with combined therapy: surgery, radiotherapy, and chemotherapy (BCNU or CCNU). A total of 102 patients were treated, 50 with BCNU, and 52 with CCNU. The overall response (R. + P.R.) was 68% for the BCNU group, and 65% for the CCNU group. No significant differences were found between the two types of treatment, either in terms of response or in terms of quality and length of survival.
Similar content being viewed by others
References
Armentrout, S. A., Foltz, E., Vermund, H., Otis, P. T., Comparison of postoperative irradiation alone and in combination with BCNU (NSC 409962) in the management of malignant gliomas. Cancer Chemother. Rep.58 (1974), 841–844.
Barker, M., Hoshino T., Gurcay, O., Wilson, C. B., Hielsen, S. L., Downie, R., Eliason, J., Development of an animal brain tumour model and its response to therapy with l,3-bis-(2-chloroethyl)-1-nitrosourea. Cancer Res.33 (1973), 976–986.
Bouchard, J., Radiation therapy of tumours and diseases of the central nervous system, p. 244. Philadelphia: Lea and Febiger. 1966.
Brain tumors, Vol. II (Wilson, C. B., ed.), pp. 1–74. Seminars in Oncology. 1975.
Broder, L. E., Carter, S. K., BCNU (NSC 409962), Clinical Brochure, N.I.H., Bethesda, Md. 1970.
Broder, L. E., Rall, D. P., Chemotherapy of brain tumours. Prog. exp. Tumor Res.37 (1972), 373–399.
Chang, C. H., Some new radiotherapeutic approaches and combined protocol trials in the management of malignant gliomas. In: Gliomas: Current concepts in biology, diagnosis and therapy, pp. 135–149 (Hekmatpanah, J., ed.). Berlin-Heidelberg-New York: Springer. 1975.
Costans, J. P., Cioloca, C., Tumeurs cérébrales e chimiothérapie antimitotique. Paris: Masson et Cie. 1957.
Crivelli, G., Monfardini, S., Morello, G., Bonadonna, G., Controlled study with adjuvant chemotherapy following surgery plus radiotherapy in glioblastoma multiforme. XL World Cancer Congress, Firenze 1974.
Cutler, S. J., Young, J. L. (eds.), Third National Cancer Survey: Incidence Data. Nat. Cancer Inst. Monogr.41 (1975), 1–454.
Hansen, H. H., Selawry, O. S., Muggia, F. M., Walker, M. D., Clinical studies with l-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79039). Cancer Res.31 (1971), 223–227.
Hildebrand, J., Brihaye, J., Wagenknecht, J., Michel, J., Kenis, Y., Combination chemotherapy with 1-(2-chloroethyl)-3-cyclohexil-nitrosourea (CCNU), vincristine and methotrexate in primary and metastatic brain tumors. A preliminary report. Europ. J. Cancer9 (1973), 627–634.
Hildebrand, J., Brihaye, J., Malignant gliomas: Prognostic factors and criteria of resoonse. In: Cancer therapy: Prognostic factors and criteria of response, pp. 307–318 (Staquet, M. J., ed.). New York: Raven Press. 1975.
Introzzi, G., Paoletti, P., Pezzotta, S., Robustelli della Cuna, G., Rodriguezy Baena, R., The use of BCNU in chemotherapy of tumors of the central nervous system. J. Neurosurg. Sci.19 (1975), 223–225.
Mealey, J. Jr., Chen, T. T., Pedlow, E., Brain tumor chemotherapy with mytramicine and vincristine. Cancer26 (1970), 360–367.
Morley, T. P., Does radiation therapy improve the treatment of intracranial gliomas? In: Ontario cancer treatment research brochure, pp. 54–70. Toronto, Canada. Nov. 1967.
Morley, T. P., The failure of radiation therapy to improve the survival period in gliomas: A controlled study. Presented at the American Association of Neurological Surgeons, April 1968, Chicago, Ill., U.S.A.
Posner, J. B., Shapiro, W. R., Brain tumor: current status of treatment and its complications. Arch. Neurol.32 (1975), 781–784.
Reagan, T. J., Bisel, F. H., Childs, D. S., Jr., Layton, D. D., Rhoton, A. L., Jr., Taylor, W. F., Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg.44 (1976), 186–190.
Robustelli della Cuna, G., Paoletti, P., BCNU and CCNU chemotherapy of tumors of the central nervous system. In: Chemotherapy: Cancer chemotherapy II, Vol. 8, pp. 541–549 (Hellmann, K., Connors, T. A., eds.). Plenum Press. 1975.
Robustelli della Cuna, G., La Chemioterapia dei Tumori del Sistema Nervoso Centrale von derivati della Nitrosourea. In: Progressi in Chemioterapia Antitumorale, pp. 143–153 (Ransa, L., Velo, G. P., eds.). Milano: Casa Editrice Ambrosiana. 1976.
Walker, M. D., Gehan, E. A., An evaluation of l-3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and irradiation alone and in combination for the treatment of malignant glioma. In: Proceedings of the 63rd Annual Meeting of the American Association of Cancer Research. Proc. Amer. Assoc. Cancer Res.13 (1972), 67.
Walker, M. D., Nitrosoureas in central nervous system tumors. Cancer Chemother. Rep.4 (1973), 21–26.
Walker M. D., Brain and peripheral nervous system tumours. In: Cancer Medicine, pp. 1385–1405 (Holland, J. F., Frei, E. III, eds.). Philadelphia: Lea and Febiger. 1973.
Walker, M. D., Gehan, E. A., Clinical studies in malignant gliomas and their treatment with the nitrosoureas. Cancer Treat. Rev.60 (1976), 713–716.
Wilson, C. B., Chemotherapy: Current results and future prospects. In: Gliomas: Current concepts in biology, diagnosis and therapy, pp. 119–124 (Hekmatpanah, J., ed.). Berlin-Heidelberg-New York: Springer. 1975.
Withmore, G., Stanners, D., Till, J., Gulias, G., Nucleic acid synthesis and division cycle in X-irradiated L. strain mouse cells. Biochem. Biophys. Acta47 (1961), 66–71.
Author information
Authors and Affiliations
Additional information
This work was supported by the United States Public Health Service Grant No. 080090/4 from the National Institutes of Neurology and Blindness, Bethesda, U.S.A., and by the National Research Council, Rome, Italy.
Rights and permissions
About this article
Cite this article
Paoletti, P., Robustelli della Cuna, G., Knerich, R. et al. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds. Acta neurochir 41, 287–299 (1978). https://doi.org/10.1007/BF01811342
Issue Date:
DOI: https://doi.org/10.1007/BF01811342